BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2136901)

  • 1. Neonatal tolerance induction by class II alloantigens activates IL-4-secreting, tolerogen-responsive T cells.
    Powell TJ; Streilein JW
    J Immunol; 1990 Feb; 144(3):854-9. PubMed ID: 2136901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance to class II major histocompatibility complex molecules is maintained in the presence of endogenous, interleukin-2-producing, tolerogen-specific T lymphocytes.
    Mohler KM; Streilein JW
    J Immunol; 1987 Oct; 139(7):2211-9. PubMed ID: 2958541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular mechanisms that maintain neonatally-induced tolerance of class II alloantigens. Evidence that factor-mediated suppression silences cytotoxic T cell activity.
    Matriano JA; Socarras S; Streilein JW
    J Immunol; 1994 Aug; 153(4):1505-14. PubMed ID: 7913940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular mechanisms that maintain neonatally-induced tolerance of class II alloantigens. Evidence that precursor cytotoxic T cells are present but silenced.
    Matriano JA; Socarras S; Streilein JW
    J Immunol; 1994 Aug; 153(4):1515-26. PubMed ID: 8046230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient T and B cell activation after neonatal induction of tolerance to MHC class II or Mls alloantigens.
    Schurmans S; Brighouse G; Kramer G; Wen L; Izui S; Merino J; Lambert PH
    J Immunol; 1991 Apr; 146(7):2152-60. PubMed ID: 1672344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of neonatal transplantation tolerance.
    Streilein JW; Mohler K; Wood PJ
    Transplant Proc; 1987 Dec; 19(6 Suppl 7):82-7. PubMed ID: 2962357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for involvement of clonal anergy in MHC class I and class II disparate skin allograft tolerance after the termination of intrathymic clonal deletion.
    Tomita Y; Nishimura Y; Harada N; Eto M; Ayukawa K; Yoshikai Y; Nomoto K
    J Immunol; 1990 Dec; 145(12):4026-36. PubMed ID: 2147933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of immunological tolerance to major histocompatibility complex antigens. I. High frequencies of tolerogen-specific cytotoxic T lymphocyte precursors in mice neonatally tolerized to class I major histocompatibility complex antigens.
    Heeg K; Wagner H
    Eur J Immunol; 1985 Jan; 15(1):25-30. PubMed ID: 2578397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo functional clonal deletion of recipient CD4+ T helper precursor cells that can recognize class II MHC on injected donor lymphoid cells.
    Kiziroglu F; Miller RG
    J Immunol; 1991 Feb; 146(4):1104-12. PubMed ID: 1671401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allo-I-J determinants participate in maintenance of neonatal H-2 tolerance.
    Mohler KM; Strome PG; Streilein JW
    J Immunol; 1987 Jan; 138(1):70-7. PubMed ID: 2946781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential susceptibility of cytotoxic and helper T cell precursors to neonatal tolerization to histocompatibility antigens.
    Ishizaka ST; Carnaud C; Stutman O
    J Immunol; 1986 Oct; 137(7):2093-9. PubMed ID: 2944947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Property of class I H-2 alloantigen-reactive Lyt-2+ helper T cell subset. Abrogation of its proliferative and IL-2-producing capacities by intravenous injection of class I H-2-disparate allogeneic cells.
    Sato S; Azuma T; Shimizu J; Shima J; Kitagawa S; Hamaoka T; Fujiwara H
    J Immunol; 1988 Aug; 141(3):721-7. PubMed ID: 2456330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of cytotoxic cells in mice rendered neonatally tolerant of MHC alloantigens: evidence for repertoire modification.
    Wood PJ; Strome PG; Streilein JW
    J Immunol; 1987 Jun; 138(11):3661-8. PubMed ID: 2884256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ontogeny of tolerogen-responsive lymphocytes following neonatal inoculation of class II disparate semiallogeneic cells.
    Socarras S; Matriano J; Powell TJ; Streilein JW
    Transpl Immunol; 1993; 1(2):114-25. PubMed ID: 8081769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ontogeny of tolerogen-responsive lymphocytes following neonatal inoculation of class II disparate semiallogeneic cells.
    Socarras S; Matriano J; Streilein JW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):354-6. PubMed ID: 8438332
    [No Abstract]   [Full Text] [Related]  

  • 16. Autoimmunity following neonatal tolerance to alloantigens: role of donor I-A and I-E molecules.
    Kramar G; Schurmans S; Berney M; Izui S; del Giudice G; Lambert PH
    J Autoimmun; 1995 Apr; 8(2):177-92. PubMed ID: 7612147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft.
    Hori S; Sato S; Kitagawa S; Azuma T; Kokudo S; Hamaoka T; Fujiwara H
    J Immunol; 1989 Sep; 143(5):1447-52. PubMed ID: 2527264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo treatment of neonatal mice with anti-I-A antibodies interferes with the development of the class I, class II, and Mls-reactive proliferating T cell subset.
    Kruisbeek AM; Bridges S; Carmen J; Longo DL; Mond JJ
    J Immunol; 1985 Jun; 134(6):3597-604. PubMed ID: 3157745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphokine production by MLR-reactive reaction lymphocytes obtained from normal mice and mice rendered tolerant of class II MHC antigens.
    Mohler KM; Streilein JW
    Transplantation; 1989 Apr; 47(4):625-33. PubMed ID: 2523101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early loss of precursors of CTL and IL 2-producing cells in the development of neonatal tolerance to alloantigens.
    Carnaud C; Ishizaka ST; Stutman O
    J Immunol; 1984 Jul; 133(1):45-51. PubMed ID: 6233373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.